Cullinan Associates Inc Novartis Ag Transaction History

Cullinan Associates Inc

$1.76 Billion
Q1 2024

A detailed history of Cullinan Associates Inc transactions in Novartis Ag stock. As of the latest transaction made, Cullinan Associates Inc holds 4,700 shares of NVS stock, worth $500,268. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,700

Previous 4,600 2.17%

Holding current value

$500,268

Previous $464,000 2.16%

% of portfolio

0.03%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	BUY	$95.27 - $108.47 $9,527 - $10,847	100 Added 2.17%	4,700 $454,000
Q4 2023 Jan 24, 2024	SELL	$92.27 - $101.54 $18,454 - $20,308	-200 Reduced 4.17%	4,600 $464,000
Q2 2023 Jul 14, 2023	BUY	$92.52 - $104.91 $18,504 - $20,982	200 Added 4.35%	4,800 $484,000
Q1 2023 Apr 05, 2023	SELL	$80.03 - $92.81 $103,718 - $120,281	-1,296 Reduced 21.98%	4,600 $423,000
Q4 2022 Jan 11, 2023	BUY	$75.55 - $92.52 $90,357 - $110,653	1,196 Added 25.45%	5,896 $535,000

Q3 2022 Oct 19, 2022	BUY	$74.61 - $87.26 $14,922 - $17,452	200 Added 4.44%	4,700 $357,000
Q1 2022 Apr 21, 2022	SELL	$80.11 - $90.62 $13,218 - $14,952	-165 Reduced 3.54%	4,500 $395,000
Q4 2021 Jan 07, 2022	SELL	$79.7 - $88.13 $103,610 - $114,569	-1,300 Reduced 21.79%	4,665 $408,000
Q3 2021 Oct 08, 2021	BUY	$81.78 - $95.14 $13,493 - $15,698	165 Added 2.84%	5,965 $488,000
Q2 2021 Jul 07, 2021	SELL	$85.24 - $94.15 $9,546 - $10,544	-112 Reduced 1.89%	5,800 $529,000
Q2 2020 Jul 07, 2020	BUY	$80.93 - $91.1 $30,753 - $34,618	380 Added 6.87%	5,912 $516,000
Q1 2020 Apr 01, 2020	SELL	$70.67 - $99.01 $38,444 - $53,861	-544 Reduced 8.95%	5,532 $456,000
Q4 2019 Jan 15, 2020	BUY	$84.35 - $95.37 $123,488 - $139,621	1,464 Added 31.74%	6,076 $575,000
Q4 2018 Jan 11, 2019	BUY	$73.66 - $82.02 $74,543 - $83,004	1,012 Added 28.11%	4,612 $396,000
Q3 2017 Oct 16, 2017	BUY	$74.14 - $77.27 $266,904 - $278,172	3,600	3,600 $309,000

Others Institutions Holding NVS

# of Institutions

1,346

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cullinan Associates Inc with notifications on news.

Account

Cullinan Associates Inc Novartis Ag Transaction History